Efficacy of donepezil for the treatment of oxaliplatin-induced peripheral neuropathy: DONEPEZOX, a protocol of a proof of concept, randomised, triple-blinded and multicentre trial

被引:0
|
作者
Nicolas Kerckhove
David Tougeron
Côme Lepage
Denis Pezet
Karine Le Malicot
Manon Pelkowski
Bruno Pereira
David Balayssac
机构
[1] CHU Clermont-Ferrand,UMR 1107 NEURODOL, service de pharmacologie médicale
[2] Université Clermont Auvergne,Service d’Hépato gastroentérologie
[3] INSERM,Service d’Hépatogastroentérologie et oncologie digestive
[4] CHU Poitiers,UMR LNC 1231
[5] CHU Dijon,Service de chirurgie digestive, U1071, M2iSH, USC
[6] Université de Bourgogne,INRA 2018
[7] EPICAD INSERM,Direction de la recherche clinique et de l’innovation
[8] Université de Bourgogne,undefined
[9] CHU Clermont-Ferrand,undefined
[10] Université Clermont Auvergne,undefined
[11] INSERM,undefined
[12] INRA,undefined
[13] Fédération Francophone de Cancérologie Digestive (FFCD),undefined
[14] CHU Clermont-Ferrand,undefined
来源
BMC Cancer | / 22卷
关键词
Pain; Chemotherapy-induced peripheral neuropathy; Anticholinesterase; Donepezil; Oxaliplatin; Study protocol;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 17 条
  • [1] Efficacy of donepezil for the treatment of oxaliplatin-induced peripheral neuropathy: DONEPEZOX, a protocol of a proof of concept, randomised, triple-blinded and multicentre trial
    Kerckhove, Nicolas
    Tougeron, David
    Lepage, Come
    Pezet, Denis
    Le Malicot, Karine
    Pelkowski, Manon
    Pereira, Bruno
    Balayssac, David
    BMC CANCER, 2022, 22 (01)
  • [2] Efficacy and safety of electroacupuncture for oxaliplatin-induced peripheral neuropathy in colorectal cancer patients: a single-blinded, randomized, sham-controlled trial
    Chan, Kaiyin
    Lui, Louisa
    Lam, Yukting
    Yu, Kaling
    Lau, Kwongwai
    Lai, Manchi
    Lau, Waiwai
    Tai, Lokyin
    Mak, Chunkin
    Bian, Zhaoxing
    Zhong, Linda L. D.
    ACUPUNCTURE IN MEDICINE, 2023, 41 (05) : 268 - 283
  • [3] Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial - CALGB/alliance 170601
    Smith, E. M. L.
    Pang, H.
    Ye, C.
    Cirrincione, C.
    Fleishman, S.
    Paskett, E. D.
    Ahles, T.
    Bressler, L. R.
    Le-Lindqwister, N.
    Fadul, C. E.
    Loprinzi, C.
    Shapiro, C. L.
    EUROPEAN JOURNAL OF CANCER CARE, 2017, 26 (02)
  • [4] Study protocol: fish oil supplement in prevention of oxaliplatin-induced peripheral neuropathy in adjuvant colorectal cancer patients - a randomized controlled trial. (OxaNeuro)
    Gehr, Nina Lykkegaard
    Karlsson, Pall
    Timm, Signe
    Christensen, Signe
    Hvid, Christian Andreas
    Peric, Jana
    Hansen, Torben Frostrup
    Lauritzen, Lotte
    Finnerup, Nanna Brix
    Ventzel, Lise
    BMC CANCER, 2024, 24 (01)
  • [5] Monosialotetrahexosylganglioside in the treatment of chronic oxaliplatin-induced peripheral neurotoxicity: TJMUCH-GI-001, a randomised controlled trial
    Zhou, Likun
    Liu, Rui
    Huang, Dingzhi
    Li, Hongli
    Ning, Tao
    Zhang, Le
    Ge, Shaohua
    Bai, Ming
    Wang, Xia
    Yang, Yuchong
    Wang, XinYi
    Chen, Xingyun
    Gao, Zhiying
    Luo, Laizhi
    Yang, Yuanquan
    Wu, Xi
    Deng, Ting
    Ba, Yi
    ECLINICALMEDICINE, 2021, 41
  • [6] Prevention of oxaliplatin-induced peripheral neuropathy by a polyamine-reduced diet-NEUROXAPOL: protocol of a prospective, randomised, controlled, single-blind and monocentric trial
    Balayssac, David
    Ferrier, Jeremy
    Pereira, Bruno
    Gillet, Brigitte
    Petorin, Caroline
    Vein, Julie
    Libert, Frederic
    Eschalier, Alain
    Pezet, Denis
    BMJ OPEN, 2015, 5 (04):
  • [7] Study protocol: fish oil supplement in prevention of oxaliplatin-induced peripheral neuropathy in adjuvant colorectal cancer patients – a randomized controlled trial. (OxaNeuro)
    Nina Lykkegaard Gehr
    Páll Karlsson
    Signe Timm
    Signe Christensen
    Christian Andreas Hvid
    Jana Peric
    Torben Frøstrup Hansen
    Lotte Lauritzen
    Nanna Brix Finnerup
    Lise Ventzel
    BMC Cancer, 24
  • [8] Electroacupuncture for chemotherapy-induced peripheral neuropathy: study protocol for a pilot multicentre randomized, patient-assessor-blinded, controlled trial
    Joo-Hee Kim
    Eun-Jung Kim
    Byung-Kwan Seo
    Sanghun Lee
    Seunghoon Lee
    So-Young Jung
    Min-Hee Lee
    Ae-Ran Kim
    Hyo-Ju Park
    Mi-Suk Shin
    Sun-Mi Choi
    Trials, 14
  • [9] Electroacupuncture for chemotherapy-induced peripheral neuropathy: study protocol for a pilot multicentre randomized, patient-assessor-blinded, controlled trial
    Kim, Joo-Hee
    Kim, Eun-Jung
    Seo, Byung-Kwan
    Lee, Sanghun
    Lee, Seunghoon
    Jung, So-Young
    Lee, Min-Hee
    Kim, Ae-Ran
    Park, Hyo-Ju
    Shin, Mi-Suk
    Choi, Sun-Mi
    TRIALS, 2013, 14 : 1 - 7
  • [10] Effectiveness assessment of riluzole in the prevention of oxaliplatin-induced peripheral neuropathy: RILUZOX-01: protocol of a randomised, parallel, controlled, double-blind and multicentre study by the UNICANCER-AFSOS Supportive Care intergroup
    Kerckhove, Nicolas
    Busserolles, Jerome
    Stanbury, Trevor
    Pereira, Bruno
    Plence, Valerie
    Bonnetain, Franck
    Krakowski, Ivan
    Eschalier, Alain
    Pezet, Denis
    Balayssac, David
    BMJ OPEN, 2019, 9 (06):